Dr. Sofie Hoflack, anesthesist: what changed
Dr. Sofie Hoflack, anesthesist
Largest movements
- Cash -€12,663
down €12,663 (-11.9%), from €106,614 to €93,951
mainly Other debts (-€8,236) and Investment in fixed assets (net) (-€1,609)
- Tangible fixed assets +€1,428
new in 2025: €1,428
- Other debts -€8,236
down €8,236 (-80.6%), from €10,214 to €1,978
- Reserves -€1,110
down €1,110 (-1.2%), from €94,680 to €93,571
- Gross operating margin -€50,282
down €50,282 (-99.8%), from €50,377 to €95
- Taxes -€12,565
down €12,565 (-97.6%), from €12,872 to €306
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €110,601 | €100,699 | -€9,902 | -9.0% |
| Fixed assets | 21/28 | - | €1,428 | +€1,428 | |
| Tangible fixed assets | 22/27 | - | €1,428 | +€1,428 | |
| Furniture and vehicles | 24 | - | €1,428 | +€1,428 | |
| Current assets | 29/58 | €110,601 | €99,271 | -€11,330 | -10.2% |
| Amounts receivable within one year | 40/41 | €2,128 | €3,194 | +€1,065 | +50.1% |
| Other amounts receivable | 41 | €2,128 | €3,194 | +€1,065 | +50.1% |
| Cash at bank and in hand | 54/58 | €106,614 | €93,951 | -€12,663 | -11.9% |
| Deferred charges and accrued income | 490/1 | €1,859 | €2,127 | +€268 | +14.4% |
| Total equity and liabilities | 10/49 | €110,601 | €100,699 | -€9,902 | -9.0% |
| Equity | 10/15 | €99,680 | €98,571 | -€1,110 | -1.1% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €94,680 | €93,571 | -€1,110 | -1.2% |
| Distributable reserves | 133 | €94,680 | €93,571 | -€1,110 | -1.2% |
| Amounts payable | 17/49 | €10,920 | €2,129 | -€8,792 | -80.5% |
| Amounts payable within one year | 42/48 | €10,920 | €2,129 | -€8,792 | -80.5% |
| Trade debts | 44 | €706 | €151 | -€555 | -78.6% |
| Suppliers | 440/4 | €706 | €151 | -€555 | -78.6% |
| Other amounts payable | 47/48 | €10,214 | €1,978 | -€8,236 | -80.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €506 | €181 | -€325 | -64.3% |
| Other operating charges | 640/8 | €862 | €661 | -€202 | -23.4% |
| Gross operating margin | 9900 | €50,377 | €95 | -€50,282 | -99.8% |
| Operating profit (loss) | 9901 | €49,009 | -€746 | -€49,755 | |
| Financial charges | 65/66B | €74 | €58 | -€16 | -21.8% |
| Recurring financial charges | 65 | €74 | €58 | -€16 | -21.8% |
| Profit (loss) for the period before taxes | 9903 | €48,935 | -€804 | -€49,739 | |
| Income taxes | 67/77 | €12,872 | €306 | -€12,565 | -97.6% |
| Profit (loss) for the period | 9904 | €36,064 | -€1,110 | -€37,174 | |
| Profit (loss) for the period to be appropriated | 9905 | €36,064 | -€1,110 | -€37,174 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.